Quantitative proteomics of parotid saliva in primary Sjögren's syndrome

Proteomics

Volumn 12, Issue 19-20, 2012, Pages 3113-3120

  Ambatipudi, Kiran S ^a   Swatkoski, Stephen ^b   Moresco, James J ^c   Tu, Patricia G ^c   Coca, Andreea ^d   Anolik, Jennifer H ^d   Gucek, Marjan ^b   Sanz, Igñacio ^d   Yates, John R ^c   Melvin, James E ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Autoimmune; Biomarkers; Biomedicine; Label free quantitation; Parotid saliva; Sj gren's syndrome

Indexed keywords

PROTEOME; SALIVA PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MULTIDIMENSIONAL PROTEIN IDENTIFICATION TECHNOLOGY; PAROTID GLAND; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; SALIVA; SJOEGREN SYNDROME;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATABASES, PROTEIN; FEMALE; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PAROTID GLAND; PROTEOMICS; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SJOGREN'S SYNDROME;

EID: 84867824228     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200208     Document Type: Article

References (37)

1. Fox, R. I., Sjögren's syndrome. Lancet 2005, 366, 321-331.
2. Kassan, S. S., Thomas, T. L., Moutsopoulos, H. M., Hoover, R. et al., Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med. 1978, 89, 888-892.
3. Pink, R., Simek, J., Vondrakova, J., Faber, E. et al., Saliva as a diagnostic medium. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2009, 153, 103-110.
4. Hu, S., Wang, J., Meijer, J., Ieong, S. et al., Salivary proteomics and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum. 2007, 56, 3588-3600.
5. Andonopoulos, A. P., Drosos, A. A., Skopouli, F. N., Moutsopoulos, H. M., Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study. Clin. Exp. Rheumatol. 1989, 7, 203-205.
6. Salliot, C., Mouthon, L., Ardizzone, M., Sibilia, J. et al., Sjögren's syndrome is associated with and not secondary to systemic sclerosis. Rheumatology 2007, 46, 321-326.
7. Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M. et al., Classification criteria for Sjögrens syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61, 554-558.
8. Harley, J. B., Scofield, R. H., Systemic lupus erythematosus: RNA protein autoantigens, models of disease heterogeneity, and theories of etiology. J. Clin. Immunol. 2005, 11, 297-316.
9. Hendrick, J. P., Wolin, S. L., Rinke, J., Lerner, M. R. et al., Ro small cytoplasmic ribonuclearproteins are a subclass of La ribonuclearproteins: further characterization of the Ro and La small ribonuclearproteins from uninfected mammalian cells. Mol. Cell Biol. 1981, 1, 1138-1149.
10. Ryu, O. H., Atkinson, J. C., Hoehn, G. T., Illei, G. G. et al., Identification of parotid salivary biomarkers in Sjögren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 2006, 45, 1077-1086.
11. Rao, V. P., Reddy, A. P., Lu, X., Dasari, S. et al., Proteomic identification of salivary biomarkers of type-2 diabetes. J. Proteome Res. 2009, 8, 239-245.
12. Giusti, L., Baldini, C., Bazzichi, L., Ciregia, F. et al., Proteome analysis of whole saliva: a new tool for rheumatic diseases - the example of Sjögren's syndrome. Proteomics 2007, 7, 1634-1643.
13. Peluso, G., De Santis, M., Inzitari, R., Fanali, C. et al., Proteomic study of salivary peptides and proteins in patients with Sjögrens syndrome before and after pilocarpine treatment. Arthritis Rheum. 2007, 56, 2216-2222.
14. Ching, K. H., Burbelo, P. D., Gonzalez-Begne, M., Roberts, M. E. P. et al., Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjögrens syndrome. J. Dent. Res. 2011, 90, 445-449.
15. Baldini, C., Giusti, L., Ciregia, F., Da Valle, Y. et al., Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res. Ther. 2011, 13, R194.
16. Streckfus, C. F., Dubinsky, W. P., Proteomics analysis of saliva for cancer diagnosis. Expert Rev. Proteomics 2007, 4, 329-332.
17. Washburn, M. P., Wolters, D., Yates, J. R. III., Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
18. Lashley, K., Reflex secretion of the human parotid gland. J. Exp. Psychol. 1916, 1, 461-493.
19. Ambatipudi, K. S., Lu, B., Hagen, F. K., Melvin, J. E. et al., Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J. Proteome Res. 2009, 8, 5093-5102.
20. Zhan, X., Desiderio, D. M., Signaling pathway networks mined from human pituitary adenoma proteomics data. BMC Med. Genomics 2010, 3, 13.
21. McDonald, W. H., Tabb, D. L., Sadygov, R. G., MacCoss, M. J. et al., MS1, MS2, and SQT-three unified, compact, and easily parsed file formats for the storage of shotgun proteomic spectra and identifications. Rapid Commun. Mass Spectrom. 2004, 18, 2162-2168.
22. Peng, J., Elias, J. E., Thoreen, C. C., Licklider, L. J. et al., Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res, 2003, 2, 43-50.
23. Xu, T., Venable, J. D., Park, S. K., Cociorva, D. et al., ProLuCID: a fast and sensitive tandem mass spectra-based protein identification program. Mol. Cell Proteomics 2006, 5, S174.
24. Tabb, D. L., McDonald, W. H., Yates, J. R. III., DTA Select and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 2002, 1, 21-26.
25. Wang, G., Wu, W. W., Zeng, X., Chou, C.-L. et al., Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: reproducibility, linearity, and application with complex proteome. J. Proteome Res. 2006, 5, 1214-1223.
26. Beeley, J. A., Khoo, K. S., Salivary proteins in rheumatoid arthritis and Sjögren's syndrome: one dimensional and two-dimensional electrophoretic studies. Electrophoresis 1999, 20, 1652-1660.
27. Liu, H., Sadygov, R. G., Yates, J. R. 3rd., A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76, 4193-4201.
28. Hu, S., Gao, K., Pollard, R., Arellano-Garcia, M. et al., Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res. 2010, 62, 1633-1638.
29. Carr, S. A., Anderson, L., Protein quantitation through targeted mass spectrometry: the way out for biomarker purgatory? Clin. Chem. 2008, 54, 1749-1752.
30. Gonzalez-Begne, M., Lu, B., Han, X., Hagen, F. K. et al., Proteomic analysis of human parotid gland exosome by multidimensional protein identification technology (MudPIT). J. Proteome Res. 2009, 8, 1304-1314.
31. + T cells by dendritic cell-derived exosomes. Nat. Immunol. 2002, 3, 1156-1162.
32. Sfriso, P., Ostuni, P., Botosios, C., Andretta, M. et al., Serum and salivary neopterin and interferon-gamma in primary Sjögren's syndrome. Correlation with clinical, laboratory and histopathologic features. Scan. J. Rheumatol. 2003, 32, 74-78.
33. Al-Hashimi, I., Dickinson, D. P., Levine, M. J., Purification, molecular cloning, and sequencing of salivary cystatin SA-1. J. Biol. Chem. 1998, 263, 9381-9387.
34. Robinson, C. P., Yamachika, S., Alford, C. E., Cooper, C. et al., Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren's syndrome. Proc. Natl. Acad. Sci. 1997, 94, 5767-5771.
35. Fox, R. I., Kang, H. I., Ando, D., Abrams, J. et al., Cytokine mRNA expression in salivary gland biopsies of Sjögrens syndrome. J. Immunol. 1994, 152, 5532-5539.
36. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2010, 8, 967-974.
37. Yu, D., Vinuesa, C. G., Multiple checkpoints keep follicular helper T cells under control to prevent autoimmunity. Cell Mol. Immunol. 2010, 7, 198-203.